Header cover image

Pharmaceuticals & Biotech Biotech Breakthroughs

Results

108

0 new

Companys with strong funding and high growth potential

108 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BOVN.F

BioInvent International		SEK 4.700%n/aSEK 2.7bSEK 12.58PS9.2xE62.0%n/a

BXPH.F

Botanix Pharmaceuticals		AU$0.29-10.9%44.5%AU$689.3mn/aPS333.1xE99.4%n/a

AXSM

Axsome Therapeutics		US$89.64-5.0%22.7%US$4.3bUS$125.24PS14.8xE68.9%n/a

ZVRA

Zevra Therapeutics		US$7.31-8.9%47.5%US$397.0mUS$20.50PS16.2xE68.5%n/a

IMGN

ImmunoGen		US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

SGEN

Seagen		US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

IVVD

Invivyd		US$1.04-14.8%-41.2%US$117.1mUS$8.65PS54.9xE70.4%n/a

ARGX

argenx		€524.58-2.2%7.9%€28.5b€562.17PS19.2xE58.4%n/a

ARGN.F

argenx		€525.600%n/a€29.0b€553.40PS19.5xE58.4%n/a

ARDX

Ardelyx		US$6.366.2%57.4%US$1.4bUS$11.28PS7.1xE66.3%n/a

ITCI

Intra-Cellular Therapies		US$73.21-4.9%36.1%US$7.9bUS$96.13PS13.7xE64.4%n/a

BRCT.F

BioArctic		SEK 16.04-5.0%-37.1%SEK 14.4bSEK 28.25PS48.7xE98.4%0%

AKES.F

Akeso		HK$8.40-0.9%n/aHK$55.4bHK$8.64PS26.6xE54.5%n/a

BPMC

Blueprint Medicines		US$89.06-2.1%74.4%US$5.5bUS$127.35PS15.6xE67.4%n/a

AVDL

Avadel Pharmaceuticals		US$12.60-7.4%n/aUS$1.2bUS$23.90PS12.7xE62.2%n/a

ISEE

IVERIC bio		US$39.950.9%236.3%US$5.5bUS$40.00PB11.6xE59.0%n/a

IVBI.Y

Innovent Biologics		HK$22.000%n/aHK$73.1bHK$28.79PS8.8xE59.4%n/a

TSVT

2seventy bio		US$4.76-2.3%25.9%US$222.5mUS$8.25PS5.6xE76.5%n/a

CAPR

Capricor Therapeutics		US$9.99100.2%71.8%US$365.4mUS$31.00PS13xE68.7%n/a

URGN

UroGen Pharma		US$12.75-7.9%-10.8%US$541.6mUS$43.10PS6.3xE55.1%n/a

MGTX

MeiraGTx Holdings		US$4.18-4.1%-15.9%US$311.1mUS$20.60PS39.8xE7.8%n/a

SLNO

Soleno Therapeutics		US$48.77-7.5%76.8%US$1.9bUS$70.29PB6.8xE68.2%n/a

EVOK

Evoke Pharma		US$5.0814.4%-60.8%US$3.5mUS$18.00PB1.4xE117.2%n/a

SWTX

SpringWorks Therapeutics		US$32.29-8.7%37.6%US$2.4bUS$68.13PS27.8xE75.6%n/a
Page 1 of 5
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.